©The Author(s) 2019.
World J Hepatol. Aug 27, 2019; 11(8): 613-618
Published online Aug 27, 2019. doi: 10.4254/wjh.v11.i8.613
Published online Aug 27, 2019. doi: 10.4254/wjh.v11.i8.613
Table 1 Diseases associated to porto sinusoidal vascular liver disease
| Thrombophilia |
| Myeloproliferative neoplasm |
| Protein S or C deficiency |
| Antiphospholipid antibodies |
| Lupus anticoagulant |
| Factor V Leiden |
| Prothrombin mutation |
| Hematologic disease |
| Myeloproliferative neoplasm (polycythemia vera, chronic myelogenous leukaemia, essential thrombocythemia) |
| Myeloid metaplasia |
| Lymphoproliferative conditions (Hodgkin’s disease, non-Hodgkin’s lymphoma, chronic lymphocytic leukaemia and multiple myeloma) |
| Spherocytosis |
| Genetic disorders |
| Cystic fibrosis |
| Adams Oliver syndrome |
| Turner‘s disease |
| Autoimmune disease |
| Rheumatoid arthritis |
| Systemic lupus erythematosus |
| Systemic sclerosis |
| Scleroderma |
| Gut diseases |
| Celiac disease |
| Inflammatory bowel disease |
| Drug and toxics |
| Oxaliplatin |
| Azathioprine |
| 6-thioguanine |
| Arsenic |
| Busulfan |
| Cytosine arabinoside |
| Cyclophosphamide |
| Bleomycin |
| Chlorambucil |
| Doxyrubicin |
| Carmustine |
| Acquired and congenital immunodeficiency |
| Human immunodeficiency virus |
| Primary antibody-deficiency syndrome |
- Citation: Gioia S, Nardelli S, Ridola L, d’Amati G, Riggio O. Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis? World J Hepatol 2019; 11(8): 613-618
- URL: https://www.wjgnet.com/1948-5182/full/v11/i8/613.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i8.613